Money and Me: S-REITs’ 2023 outlook
[ad_1] 3 January 2023 Money and Me: S-REITs’ 2023 outlook Which SREITs stand to become beneficiaries of investors seeking resilient yield and growth opportunities in a high interest rate environment?…
Exploring the Official StockCharts Mobile App | StockCharts In Focus
[ad_1] On this week’s edition of StockCharts TV‘s StockCharts in Focus, Grayson takes you on a tour through the brand new StockCharts mobile app for iOS devices! You can now take your…
Dollar: the immediate prospects – Analytics & Forecasts – 4 January 2023
[ad_1] The focus of traders today is the publication (at 15:00 GMT) of the Institute for Supply Management (ISM) report with the most important indicators reflecting the state of the…
Eisai, Biogen get U.S. FDA approval for Alzheimer’s drug, apply for full approval By Reuters
[ad_1] © Reuters. FILE PHOTO: The logo of Eisai Co Ltd is displayed at the company headquarters in Tokyo, Japan, March 8, 2018. REUTERS/Issei Kato By Julie Steenhuysen and Deena…
How to be an optimist in markets
[ad_1] If investors are to learn anything from the grim experience of 2022 in markets, it should be How To Be An Optimist. This is not easy, especially while enduring…